Yuhan Corporation (KRX:000100)
South Korea · Delayed Price · Currency is KRW 69,800
-400 (-0.57%)
Last updated: Jul 1, 2026, 2:39 PM KST
Yuhan Market Cap
Yuhan has a market cap or net worth of 5.24 trillion as of June 30, 2026. Its market cap has decreased by -32.66% in one year.
Market Cap
5.24T
Enterprise Value
5.24T
Revenue
2.22T
Ranking
n/a
PE Ratio
25.03
Stock Price
69,800.00
Market Cap Chart
Since April 26, 2001, Yuhan's market cap has increased from 231.73B to 5.24T, an increase of 2,160.09%. That is a compound annual growth rate of 13.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 5.24T | -37.58% |
| Dec 30, 2025 | 8.39T | -6.18% |
| Dec 30, 2024 | 8.94T | 73.59% |
| Dec 28, 2023 | 5.15T | 25.86% |
| Dec 29, 2022 | 4.09T | -3.94% |
| Dec 30, 2021 | 4.26T | -9.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hanmi Pharm. | 5.43T |
| Hanall Biopharma | 3.50T |
| Celltrion Pharm | 1.91T |
| Daewoong Pharmaceutical | 1.37T |
| GC Biopharma | 1.35T |
| Chong Kun Dang Pharmaceutical | 907.83B |
| DongKook Pharmaceutical | 853.95B |
| Boryung | 727.38B |